ArticleMolecular therapy. Methods & clinical development2021

Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice.

Katherine A White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.